Autor: "Ryder, R. E. J." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pioglitazone: reports of its death are greatly exaggerated.
Autorzy:: Ryder, R. E. J.; Pokaż więcej
Temat:: BLADDER tumors
METFORMIN
DIABETES
CLINICAL drug trials
GLYCOSYLATED hemoglobin
SERIAL publications
EVIDENCE-based medicine
DATA analysis
PIOGLITAZONE
TUMOR risk factors
THERAPEUTICS
Źródło:: Diabetic Medicine; Apr2015, Vol. 32 Issue 4, pe9-e15, 7p, 4 Charts

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2.

Tytuł:: The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.
Autorzy:: Thong, K. Y.
McDonald, T. J.
Hattersley, A. T.
Blann, A. D.
Ramtoola, S.
Duncan, C.
Carr, S.
Adamson, K.
Nayak, A. U.
Khurana, R.
Hunter, S. J.
Ali, A.
Au, S.
Ryder, R. E. J.; Pokaż więcej
Temat:: C-peptide
CREATININE
DIABETES
CLINICAL drug trials
SCIENTIFIC observation
URINALYSIS
GLUCAGON-like peptide-1 agonists
THERAPEUTICS
Źródło:: Diabetic Medicine; Apr2014, Vol. 31 Issue 4, p403-411, 9p, 1 Diagram, 3 Charts, 1 Graph

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3.

Tytuł:: The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits.
Autorzy:: Ryder, R. E. J.; Pokaż więcej
Temat:: PREVENTION of drug side effects
PANCREATITIS
PANCREATIC tumors
ANIMAL experimentation
CARDIOVASCULAR diseases risk factors
CELL receptors
DIABETES
ENZYME inhibitors
HYPOGLYCEMIC agents
META-analysis
SCIENTIFIC observation
SERIAL publications
GLUCAGON-like peptide 1
EXENATIDE
TUMOR risk factors
DISEASE risk factors
THERAPEUTICS
Źródło:: Diabetic Medicine; Oct2013, Vol. 30 Issue 10, p1148-1155, 8p, 1 Chart

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter.
Autorzy:: Ryder, R. E. J.; Pokaż więcej
Temat:: BLADDER tumors
DIABETES
CLINICAL drug trials
SERIAL publications
PIOGLITAZONE
TUMOR risk factors
THERAPEUTICS
Źródło:: Diabetic Medicine; Apr2015, Vol. 32 Issue 4, p438-439, 2p, 1 Chart

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5.

Tytuł:: The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis-what happens next? A personal viewpoint.
Autorzy:: Ryder, R. E. J.
Sen Gupta, P.
Thong, K. Y.; Pokaż więcej
Temat:: PANCREATITIS diagnosis
PEOPLE with diabetes
CLINICAL drug trials
INCRETINS
MEDICAL societies
ACUTE diseases
PANCREATITIS
EXENATIDE
GLUCAGON-like peptide-1 agonists
DISEASE risk factors
THERAPEUTICS
Źródło:: Diabetic Medicine; Dec2013, Vol. 30 Issue 12, p1510-1511, 2p

Czasopismo naukowe

Szczegóły

Informacja